Back to Back Issues Page
Regenerative Medicine: New NEI Contract for AMD Research
November 04, 2014

Regenerative Medicine: New NEI Contract for AMD Research

On October 27, 2014 Cellular Dynamics International (CDI) received a $1.2 million contract from the National Eye Institute to provide re-engineered cells to be used in regenerative medicine research for the treatment of macular degeneration.

Induced Pluripotent Stem Cells

Thanks to the work of cell biologist and co-founder of CDI, James Thompson, who was recognized by Time Magazine as "America's Best in Science and Medicine" in 2001, adult skin and blood cells can be re-programmed into embryonic stem cells, called induced pluripotent stem cells (iPS).

These iPS can then manipulated into over 200 different cell types. One of those cell types is the retinal pigment epithelial cells - a layer in the retina that often degenerates in age related macular degeneration.

Find out how these iPS will be used in future clinical trials for the treatment of AMD:

Regenerative Medicine Research for AMD

Leslie Degner, RN, BSN

Better Health for Better Vision

Back to Back Issues Page